FDA Inspection 1252477 - Devalingam Mahalingam, M.D., Ph.D. - October 18, 2024

Record Details

This FDA Inspection record concerns Devalingam Mahalingam, M.D., Ph.D., with an inspection on October 18, 2024, issued by the Chicago District Office, covering human drugs.

Company: Devalingam Mahalingam, M.D., Ph.D.
Inspection Date: October 18, 2024
Product Type: Human Drugs
Office: Chicago District Office

Open in Dashboard

ID · d9778ef5-fe8b-4df3-9f0a-45a57aa817a9

Violation Codes2

21 CFR 312.6021 CFR 50.27(b)(2)

Full citation text and observation details available on the Dashboard.